Ferring is funding exploratory, basic and clinical research grants to collect data and expand knowledge on the effects of COVID-19 on reproduction, pregnancy and neonatal health.
Ferring remains committed to building families worldwide and to supporting them from conception to birth during this challenging time.
What is of interest to Ferring
Ferring is interested in funding exploratory, basic, and clinical research grants to collect data and expand knowledge about the effects of SARS-CoV-2 on reproduction, pregnancy, and foetal/neonatal health.
The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic including but not limited to:
- Follow-up data on infected pregnant patients at different gestational stages, including spontaneous pregnancies.
- Data on the outcome of ongoing fertility care.
- Data on gametes/embryos, fresh or frozen, from patients exposed to SARS-CoV-2.
- Other information related to fertility outcomes.
The Ferring COVID-19 Investigational Grants are awarded a single time and are not renewable.
The programme will provide a limited number of research grants up to EUR 25,000 for each application.
How to apply
Please go to https://ferring.fluidreview.com/ and sign in.